Correction to: Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]
BMC Cancer. 2019 Jan 21;19(1):97.
doi: 10.1186/s12885-019-5297-x.
1 Department of Molecular & Medical Pharmacology, Ahmanson Translational Theranostics/ Imaging Division, University of California, Los Angeles, USA. jcalais@mednet.ucla.edu.
2 Department of Molecular & Medical Pharmacology, Ahmanson Translational Theranostics/ Imaging Division, University of California, Los Angeles, USA. jczernin@mednet.ucla.edu.
3 Department of Molecular & Medical Pharmacology, Ahmanson Translational Theranostics/ Imaging Division, University of California, Los Angeles, USA.
4 Department of Nuclear Medicine, University Hospital Essen, Essen, Germany.
5 Department of Medicine Statistics Core (DOMStat), UCLA CTSI Biostatistics and Computational Biology, University of California, Los Angeles, USA.
6 Department of Radiation Oncology, University of California, Los Angeles, USA.
7 Department of Radiation Oncology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA.